Dicyclomine Hydrochloride Capsule
Product Images NDC 0615-8483

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 0615-8483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dicyclomine Hydrochloride Structural Image (Dicyclomine Caps 8483 1)

Dicyclomine Hydrochloride Structural Image (Dicyclomine Caps 8483 1)
Chemical structure diagram of dicyclomine hydrochloride, showing the molecular arrangement with a molecular weight of 345.95.*
FDA Label Image

Principal Display Panel (Dicyclomine Caps 8483 2)

Principal Display Panel (Dicyclomine Caps 8483 2)
This is a drug packaging label for Dicyclomine Hydrochloride Capsules USP 10 mg, provided by NCS HealthCare of KY, LLC dba Vangard Labs. The label includes dosage strength, quantity of 30 capsules, lot number 8483-, and barcodes. It indicates manufacturing for Hikma and packaging by Vangard Labs in Glasgow, KY. Storage instructions mention controlled room temperature (20-25°C). The label is marked for institutional use only with guidance to dispense in a light-resistant container and protect from moisture.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.